Daily aspirin once again proves to be of no use and also deadly
Update January 13, 2015- Yet another study was published highlighting the risks of daily aspirin. We have been the most vocal critical of aspirin for primary prevention for at least five years.
November 17, 2014- By Steven E. Greer, MD
A Japanese trial of daily aspirin for primary prevention of stroke and MI, published in JAMA, showed no statistically significant benefit in those outcomes. However, the study did show, once again, that daily aspirin increases the rate of serious GI bleeding. Intracranial bleeding was also increased (click image above for full-screen).
Hemorrhagic Complications Associated With Aspirin
Daily aspirin for prevention of death from MI unwarranted in most people
Limitations of The Lancet papers espousing the cancer risk reduction of daily aspirin
Cardiac surgery, Cardiology, FDA, Internal medicine, JAMA, Late Breaking Data, Neurology, Neurosurgery, Policy | apples49 | 
February 5, 2015 12:44 am
